Why is Ivermectin and Iodine Being Suppressed in the UK?

In this presentation, Dr. John Campbell discusses two substances he believes are being unjustly suppressed in the UK: ivermectin and iodine.

Ivermectin

Dr. Campbell begins by introducing ivermectin, a Nobel Prize-winning drug derived from a natural bacterial product. He notes its safety and effectiveness against parasites, but highlights a “complete suppression” of the drug, as detailed in Pierre Kory’s book, The War on Ivermectin.

He shows a box of 12mg tablets he obtained from Uganda, manufactured in India, which cost just $20 for 100 tablets. He argues that this low cost, due to generic manufacturing, is the primary reason large-scale trials are not being conducted, as there is no profit incentive for pharmaceutical companies.

Dr Campbell has 3.32 million Youtube subscribers – watch the video below:

The main focus of his talk is the potential use of ivermectin for cancer. Dr. Campbell states he has received hundreds of reports from viewers claiming it has been effective against various cancers, often in combination with other drugs.

While he acknowledges the lack of clinical trials, he believes this is an interesting possibility that should be investigated. He proposes that because the drug is safe, it should be made available on a “right to try” or compassionate prescribing basis.

This would allow thousands of patients, especially those with untreatable cancers, to use it, and their outcomes could be prospectively collected and analyzed to generate valuable data.

He criticizes the British government and health authorities for their “curiosity deficit disorder” in failing to make this happen, accusing them of preventing patients from even trying a potentially life-saving drug. He notes that British doctors generally won’t prescribe it due to NICE guidelines.

Iodine

Dr. Campbell then turns to iodine, which he calls the world’s most effective antiseptic, with a history of use spanning hundreds of years. He expresses bewilderment and frustration that iodine is not available for purchase over the counter in British pharmacies.

He describes its broad-spectrum effectiveness against viruses, bacteria, and fungi, and mentions its uses for urinary and respiratory infections, as well as its necessity for thyroid health. He questions why the most basic and proven therapeutic molecule has been made essentially illegal in the UK.

He shares his personal experience of taking iodine for his prostate health. He also recounts his own experiment taking ivermectin daily for seven weeks when he had a high PSA level. It did not change his PSA, and his subsequent MRI scan showed no cancer, though he admits this doesn’t prove anything conclusively.

Dr. Campbell concludes by stating that the suppression of these readily available, inexpensive, and safe treatments feels like an attempt to keep the population sick by denying them basic medicines. He is left utterly confused by the situation. He provides a standard disclaimer, advising viewers not to start or stop any treatment based on his educational content and ends by asking viewers for their thoughts on why these substances are being withheld.

source www.youtube.com

Dr John Campbell is a British YouTuber, retired nurse educator, and author best known for his online health education videos. With a Ph.D. in nursing and decades of experience in healthcare, he turned to digital teaching in 2008, building a channel that became hugely popular during the COVID-19 pandemic. His clear and straightforward style attracted millions, though his content later drew criticism for spreading misinformation on vaccines and pandemic data.

By 2025, Campbell’s YouTube channel had more than 3.1 million subscribers and over 1.1 billion views, making him one of the most-watched independent medical commentators online. At 77, he continues producing daily content, blending bioscience, health updates, and his own interpretations of global medical news.

Leave a comment

Save my name, email, and website in this browser for the next time I comment.
Share via
Share via